This review presents and addresses the conflicting results on cardiorespiratory fitness among adults with fibromyalgia. The heterogeneity in study designs, symptom severity and the assessment protocols might partly explain these conflicting results. It also presents the possible relationship between cardiorespiratory fitness and exercise prescription, attrition from exercise/rehabilitation programmes and independence with activities of daily living.
Introduction
Fibromyalgia (FM) is characterised by widespread pain, fatigue and non-restorative sleep. In the USA, the prevalence of FM is roughly 2% of the adult population, with a ratio of approximately seven women to three men [1, 2] . Although chronic widespread pain is seen as the defining feature of FM, poor sleep and respiratory problems have also been reported and have even surpassed pain as the most prominent complaints. Decreased thoracoabdominal mobility, impaired respiratory muscle mechanics, dyspnoea and reduced cardiorespiratory fitness (CRF) have been observed for these patients [3, 4] .
General practitioners and respiratory physicians and physiotherapists should be aware of these problems to propose optimal management for these patients. Unfortunately, CRF remains overlooked. Decreased CRF can cause dyspnoea on exertion and impact the patient's functional capacities and these problems need to be addressed in rehabilitation. Guidelines for FM management recommend a multidisciplinary approach involving physicians, physiotherapists and occupational therapists, where prescription of aerobic exercises represents a significant part of the rehabilitation [5] [6] [7] .
However, the results on CRF seem to be controversial and this might explain the differences Cardiorespiratory fitness among adults with fibromyalgia observed between clinical practice guidelines (e.g. Canadian Guidelines for the Diagnosis and Management of Fibromyalgia Syndrome and American College of Sports Medicine) regarding aerobic exercise prescription [5, 6] . These conflicting results could be explained by heterogeneity in protocols used to assess CRF (e.g. maximal versus submaximal testing protocol; cycle ergometer versus treadmill testing protocol). For clinicians involved in the management of FM patients, it is important to have a clear synthesis of the evidence on CRF results and on the evaluation protocols used to produce this knowledge. Although aerobic exercise training can help in the management of symptoms and may improve CRF and functional capacities, it can also cause an increase in symptoms such as pain and dyspnoea, potentially contributing to attrition from exercise programmes [8, 9] . Furthermore, an increase in symptoms might negatively affect selfmanagement of the condition and subsequently have a negative impact on the level of participation in physical activities including exercise. This might cause deconditioning and lead to a decline in functional capacities. Furthermore, attrition from an exercise or rehabilitation programme would prevent progression toward maintenance or a return to work, which, in turn, might affect direct and indirect costs, particularly work-related costs.
The aim of this review is to synthesise the scientific evidence on CRF among women with FM to shed light on the controversies in clinical practice guidelines and provide some recommendations on the evaluation of CRF.
Cardiorespiratory fitness level
Studies showing a significantly lower CRF in participants with FM 12 studies showed a lower CRF in women with FM [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] compared with a control group or normative values. These studies were published between 1994 and 2015, and used a maximal exercise test protocol on either a cycle ergometer (n=7) or treadmill (n=5).
Altogether, the 12 studies showed that participants with FM have a significantly lower peak oxygen uptake (V′O 2 peak) compared with a control group, or were at or below the 35th percentile compared with normative values. Two studies compared their results to normative values instead of a control group without FM [18, 19] . The study by Sañudo and Galiano [19] evaluated two groups of participants with FM: a severely affected group (n=16) and a moderately affected group (n=16), on two separate occasions, approximately 1 week apart. The Fibromyalgia Impact Questionnaire (FIQ) was used to classify the participants (moderately affected and severely affected participants), using a cut-off point of 54 on the total FIQ score (<54 versus ≥54). The study found that the average V′O 2 peak of the severely affected participants was significantly lower than the moderately affected participants for both tests. When compared to American College of Sports Medicine (ACSM) normative values, the average V′O 2 peak of the moderately affected participants were at the 35th percentile, whereas the severely affected participants were under the 10th percentile [19] . For its part, the study by Soriano-Maldonado et al. [18] reported an average V′O 2 peak below the 10th percentile for an American population of the same sex and age. Figure 1 shows percentage differences in V′O 2 peak between control and FM groups [8-15, 18, 19] . This difference ranges from −11.4% to −34.3%, with lower V′O 2 peak results in all the FM groups with a mean of −24.1%.
Four of the studies [11, 13, 15, 21] identified oxygen uptake at the ventilatory anaerobic threshold (V′O 2 VAT) between the FM and control group, and one study [19] compared V′O 2 VAT between severely and moderately affected participants with FM. The four studies showed a significantly lower V′O 2 VAT in the FM group compared with the control group [11, 13, 15, 21] and the other study showed a significant difference in V′O 2 VAT between severely and moderately affected participants during the second trial only [19] . Figure 2 shows the percentage difference in V′O 2 VAT between the FM and control groups across the four studies [11, 13, 15, 21] . The percentage difference ranges from −12.8% to −37.0%, with a mean difference of −22.9%.
More specifically, seven studies [10] [11] [12] [13] [14] [15] [16] , and for the control group were 21.0±3.2 and 13.1±2.9 mL O 2 ⋅min −1 ⋅kg −1 , presenting a significant difference between both groups (V′O 2 peak: p=0.009; V′O 2 VAT: p=0.001). The authors mention that eight women with FM and 25 women from the control group met the maximal oxygen uptake (V′O 2 max) criterion. The research study by McIver et al. [14] selected eight women with FM and eight healthy controls matched for age and exercise training status. There was no significant difference in BMI between the groups. Criteria for achievement of V′O 2 max were listed and all the participants met at least two of the four criteria. V′O 2 max was 16.9±1.32 mL O 2 ⋅min for the control group, with a significant difference between both groups (p=0.035). Lund et al. [15] recruited nine women for the FM group and nine matched women for the control group, with similar age, height and weight, and did not include any trained athletes. The median (range) V′O 2 peak was 24 (21- 
Studies not showing a significant reduction in CRF in participants with FM
Six studies did not demonstrate a lower CRF in women with FM when compared with matched control participants [23] [24] [25] [26] [27] [28] . These studies were published between 1994 and 2016, and all used a cycle ergometer to evaluate CRF. Three studies used a submaximal exercise test protocol [24] [25] [26] and three studies used a maximal exercise test protocol [23, 27, 28] . None of the studies evaluated V′O 2 VAT. Therefore, the fact that these studies did not demonstrate a significantly lower CRF is based solely on V′O 2 peak.
The study by Vincent et al. [23] recruited 30 women with FM (age: 47.0±10.4 years; BMI: 25.8±4.6 kg⋅m −2 ) and 30 healthy pain-and fatigue-free women (age: 41.1±8.4 years; BMI: 26.0±4.0 kg⋅m −2 ). There was no significant difference in BMI between the groups, but there was a significant difference between the groups with regard to age (p=0.019). Therefore, they included age as a covariate in all consecutive analyses [23] . The maximal testing protocol on the cycle ergometer was not explained in detail, only that the workload was increased in increments until participants achieved V′O 2 max or exhaustion. There was no significant difference between the V′O 2 peak of the FM group and the control group (FM: 23.5±5.2 mL O 2 ⋅min −1 ⋅kg −1 ; control: 28.3±6.9 mL O 2 ⋅min −1 ⋅kg −1 ; adjusted for age, p=0.07). However, they mention that more participants with FM than participants from the control group were excluded from the test because of comorbidities. It is not clear how many participants from each group completed the maximal exercise test. Finally, the average revised FIQ total score was 43, which is considered a moderate level of FM severity.
One of the purposes of the study by Sener et al. [24] was to investigate the maximal aerobic capacity of women with FM (n=39). The results were compared with a control group of 40 BMI-matched healthy women. There was no significant difference in age between the groups. Participants' V′O 2 max was estimated using a submaximal exercise protocol (Astrand) on a computerised cycle ergometer (Monark; Sverige, Sweden 
) (p=0.8).
The remaining two studies, one by Nørregaard et al. [27] and the other by Simms et al. [28] , used a maximal exercise test on a cycle ergometer. Nørregaard et al. [27] included a control group as part of the overall study, but the control group was not part of the CRF evaluation. 126 women with FM participated in this CRF testing. The median age of the FM group was slightly lower than 47 years, ranging from 39 to 54 years. The testing protocol did not include gas exchange. The results were estimated using a formula. Therefore, the corresponding maximal performance was 21 (16-25) mL O 2 ⋅kg −1 ⋅min −1 . However, the median maximal heart rate was only 63% (44-90%) of the predicted maximal heart rate (220 − age). Considering the expected maximal heart rate, the estimated aerobic capacity (V′O 2 max) would have been 30 (24-39) mL O 2 ⋅kg −1 ⋅min −1 . This estimated V′O 2 max corresponds to the normative values for "normal" physically inactive individuals of the same age [27] . The other study by Simms et al. [28] ) did not show a significant difference (p=0.43). Figure 3 shows the percentage difference in V′O 2 peak between the FM and the control groups in studies not showing a significant difference between the two groups. However, out of the six studies, two studies were not included in figure 3 : Nielens et al. [25] used a different unit of measurement (PWC 65% per kg) and the study carried out by Nørregaard et al. [27] did not evaluate the V′O 2 peak of the control group. Of the remaining four studies, one showed V′O 2 peak results from the FM group were nonsignificantly superior to the V′O 2 peak results of the control group. The other three studies demonstrated a nonsignificant reduction in V′O 2 peak in participants from the FM group. The percentage difference between the FM and the control group ranged from 7.8% to −17.0% with a mean difference of −6.6%. The study by Nielens et al. [25] (not included in figure 3 ) showed a percentage difference of −9% with lower V′O 2 peak results from the FM group. Cycle ergometer versus treadmill testing protocol 13 out of the 18 studies [10-16, 23-28] used a cycle ergometer to evaluate CRF. All the studies showing no difference in CRF among women with FM used a cycle ergometer, and seven out of the 12 studies showing a lower CRF among women with FM used a cycle ergometer [10] [11] [12] [13] [14] [15] [16] .
Maximal versus

FM severity level
Sañudo and Galiano [19] compared the participants' V′O 2 max to the ACSM (1998) normative values and reported that participants in the moderately affected group scored in the 35th percentile compared with the severely affected participants who were under the 10th percentile. Therefore, these authors concluded that the CRF of FM participants is different based on FM severity. Furthermore, the study by Valim et al. [21] reported that participants with a CRF level below average (weak and very weak) presented the worst results with the FIQ.
Deconditioning: physiological aspects and its impact on functional capacities
Of the 18 articles identified, 12 studies showed a reduction in V′O 2 VAT and/or V′O 2 peak in women with FM compared with a control group or normative values [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . The physiological explanation for lower CRF might be due to deconditioning. Individuals with FM often adopt a more sedentary lifestyle, which might include bed rest, in response to their symptoms. This sedentary lifestyle might lead to a reduction of their CRF level and impact their functional capacities. Therefore, individuals with FM might experience more difficulties in completing certain physical activities. Furthermore, it has been suggested that FM patients have lower respiratory muscle endurance, inspiratory muscle strength and thoracic mobility [3] , which could also contribute to a lower CRF. Consequently, individuals with FM who have a secondary condition affecting Cardiorespiratory fitness among adults with fibromyalgia their V′O 2 VAT and/or V′O 2 peak, for example asthma or chronic obstructive pulmonary disease, might present with a greater reduction in their CRF that may not be entirely related to their lung disease. This can cause more dyspnoea on exertion and have a greater impact on their ability to perform certain physical activities. These observations are relevant for healthcare providers because FM could influence the prognostic outcome of patients living with other comorbidities such as asthma, chronic obstructive pulmonary disease or cardiovascular disease.
Different methods exist to measure the intensity of physical activities. These include oxygen uptake, heart rate and metabolic equivalent of tasks (METs) to name a few. METs is a measure used to describe the intensity and energy expenditure of physical activities. For example, the estimated standard METs to carry groceries up a flight of stairs is 7.5 METs [29] , which represents 26. . The energy expenditure required to complete this task might be above their V′O 2 VAT or even above their V′O 2 peak. This could result in greater difficulties completing certain daily activities or exercise, since fatigue increases significantly when working above the ventilatory anaerobic threshold and it might be impossible for some individuals with FM to complete activities above their V′O 2 peak.
Discussion
To our knowledge, this is the first review focusing on CRF in adults with FM and we found conflicting results in the current literature. Although most of the studies (12 out of 18) pointed towards a lower CRF among adults with FM, caution must be taken before drawing such a conclusion.
First, attention should be given to the heterogeneity of the methods used to evaluate CRF. The 12 studies [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] showing that women with FM have a lower CRF used a maximal exercise test protocol, whereas three [24] [25] [26] out of the six studies [23] [24] [25] [26] [27] [28] that did not demonstrate a lower CRF in women with FM used a submaximal exercise test protocol. Using a maximal exercise test provides a better estimate of V′O 2 max [6] . This might partly explain these conflicting results.
Secondly, all six studies [23] [24] [25] [26] [27] [28] that did not demonstrate a lower CRF among participants with FM used cycle ergometer protocols, whereas cycle ergometers (n=7) [10] [11] [12] [13] [14] [15] [16] and treadmills (n=5) [17] [18] [19] [20] [21] were used in the studies that identified a lower CRF. Using a treadmill in a FM population might represent a more natural type of movement, and one that is more representative of daily activities and requires less muscle strength in the lower extremities than using a cycle ergometer [30] .
Moreover, certain issues regarding the clinical profile of the participants warrant consideration. The study by Sañudo and Galiano [19] concluded that the aerobic capacity of patients with FM differs depending on the severity of the disease assessed using the FIQ. Severely affected participants showed significant statistical differences in V′O 2 peak and V′O 2 VAT compared with moderately affected participants. Furthermore, the study by Valim et al. [21] reported that participants with a CRF level below average presented the worst results with the FIQ. This inverse correlation between FM severity level and aerobic capacity may help to establish CRF subgroups based on FM severity level to optimise activity and exercise prescription. Since an association between CRF and FM symptom severity was reported, the heterogeneity of the participants' clinical profile could be another explanatory factor for these conflicting results.
Looking at the results of the studies, the two lowest mean V′O 2 [29] . On average, these activities are above the V′O 2 VAT of 3.1 METs, which might be difficult to maintain, since fatigue increases significantly when working above this threshold. Furthermore, it might be impossible for some of the participants to complete activities above their V′O 2 peak. Furthermore, the standard deviations imply that the V′O 2 peak and V′O 2 VAT measurements of some participants are even lower. Although pain is an important symptom to consider in the management of FM, CRF is as important since it could have an important impact on functional status.
In light of this review, some recommendations are proposed for future studies or clinical practice to better evaluate and understand CRF among FM participants. To minimise the heterogeneity of the participants, FM severity should be taken into consideration and the use of the revised FIQ should be considered to evaluate the FM severity level. Also, when indicated, consideration should be given to using a maximal exercise test (V′O 2 peak) on a treadmill, which, in our opinion, better reflects functional activities than a cycle ergometer. Considering it was previously reported that FM patients have decreased thoracoabdominal mobility and impaired respiratory muscles mechanics, which could increase dyspnoea symptoms [3, 4] , healthcare providers need to carefully assess FM patients to determine if dyspnoea symptoms are related to a lung disease or FM. Future studies should look at the impact of exercise training in FM patients on CRF and improvement in respiratory mechanics. Finally, none of the studies evaluated capacity to recover following a maximal exercise test. Re-evaluating participants with FM 24 h after an initial cardiorespiratory test could provide further information on their capacity to recover. This could help to optimise physical activity recommendations and minimise dropout rates from exercise and rehabilitation programmes, thus promoting independence with activities of daily living, leisure and work.
Conclusion
Studies on CRF among women with FM reveal conflicting results. The heterogeneity of the study design, participant symptom severity and the assessment protocol used might partly explain these conflicting results. However, most of the studies showed a decrease in CRF in participants with FM compared to a control group or normative values. This lower CRF might have an important impact on participants' capacity to complete certain activities. Therefore, it is an important aspect to consider in the management of this condition. 
Self-evaluation questions
